Jun 29 2012
Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) today announced the pricing of its underwritten offering of 6,154,000 shares of common stock at a price of $3.25 per share.
All of the shares in the offering are to be sold by Unilife.
The gross proceeds of the offering to the Company are expected to be $20,000,500 and net proceeds, after deducting the underwriting discount and estimated offering expenses, are expected to be approximately $18,800,475.
The Company expects to use the net proceeds from this offering to fund the continued development and supply of its diversified portfolio of advanced drug delivery systems, to purchase and operate capital equipment to expand production, and for working capital and other general corporate purposes.
The offering is expected to close on July 5, 2012 and is subject to customary closing conditions.
Jefferies & Company, Inc. and Leerink Swann LLC are acting as joint book-running managers for the offering.
SOURCE Unilife Corporation